1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics, April 2015 (p10)

Therapy Analysis & Statistics, April 2015 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

271-300 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

The 2016-2021 World Outlook for Small Molecule Kinase Inhibitors

The 2016-2021 World Outlook for Small Molecule Kinase Inhibitors

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for small molecule kinase inhibitors across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Therapy
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for non-small cell lung cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential ...

  • Industries : Therapy
The 2016-2021 World Outlook for Personal Therapy Products

The 2016-2021 World Outlook for Personal Therapy Products

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for personal therapy products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Therapy
The 2016-2021 World Outlook for Prostate Cancer Therapeutics

The 2016-2021 World Outlook for Prostate Cancer Therapeutics

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for prostate cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Therapy
The 2016-2021 World Outlook for Osteoporosis Therapeutics

The 2016-2021 World Outlook for Osteoporosis Therapeutics

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for osteoporosis therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Therapy
The 2016-2021 World Outlook for Rheumatoid Arthritis Therapeutics

The 2016-2021 World Outlook for Rheumatoid Arthritis Therapeutics

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for Rheumatoid Arthritis therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Therapy
Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2015 Update

Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • May 2015
  • by Global Data

Summary Anika Therapeutics, Inc. (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, healing, and repair. It offers solutions fo ...

  • Industries : Therapy
  • Countries : United States
Cytori Therapeutics, Inc. (CYTX) - Product Pipeline Analysis, 2015 Update

Cytori Therapeutics, Inc. (CYTX) - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • May 2015
  • by Global Data

Summary Cytori Therapeutics, Inc. (Cytori Therapeutics) is a US-based pharmaceutical company. It undertakes the development of cell therapies based on autologous adipose-derived regenerative cells (ADRCs) ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Physician Views: What scope for the next oral RA therapy?

Physician Views: What scope for the next oral RA therapy?

  • $ 695
  • Industry report
  • April 2015
  • by Firstword Pharma

The rheumatoid arthritis (RA) market is one of the largest in the pharmaceutical sector and is dominated by biologic therapies, primarily the TNF inhibitors. The three largest products in this category ...

  • Industries : Therapy
  • Countries : Europe
Argos Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Argos Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Cytori Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cytori Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Amicus Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Amicus Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Five Prime Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Five Prime Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
PTC Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

PTC Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Mast Therapeutics, Inc. (formerly ADVENTRX Pharmaceuticals, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Mast Therapeutics, Inc. (formerly ADVENTRX Pharmaceuticals, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Sarepta Therapeutics, Inc. (Formerly AVI BioPharma, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Sarepta Therapeutics, Inc. (Formerly AVI BioPharma, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Cornerstone Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cornerstone Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
United Therapeutics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

United Therapeutics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Silence Therapeutics plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Silence Therapeutics plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Cardium Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cardium Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Novelos Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Novelos Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Clovis Oncology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Clovis Oncology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : General Medicine and Specialty Medicine, Therapy
  • Countries : United States
Corcept Therapeutics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Corcept Therapeutics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Galectin Therapeutics, Inc. (Galectin Therapeutics) is a biotechnology company. The company discovers, develops and commercializes therapies for fibrotic disease and cancer. Its products include ...

  • Industries : Therapy
Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review

Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Esperion Therapeutics, Inc. (Esperion) is a biotechnology company. The company develops and commercializes oral, small molecule therapies for the treatment of patients with low-density lipoprotein ...

  • Industries : Therapy
Aratana Therapeutics Inc. (PETX) - Financial and Strategic SWOT Analysis Review

Aratana Therapeutics Inc. (PETX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Aratana Therapeutics, Inc. (Aratana) is a pet therapeutics company. It undertakes the acquisition, development and commercialization of biopharmaceutical products to address the unmet medical needs ...

  • Industries : Therapy
Repros Therapeutics Inc. (RPRX) - Financial and Strategic SWOT Analysis Review

Repros Therapeutics Inc. (RPRX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Repros Therapeutics Inc. (Repros) is a biopharmaceutical company. The company develops oral small molecule drugs for major unmet medical needs in male and female health. Its product pipeline includes ...

  • Industries : Therapy
Fresenius Kabi Oncology Limited (FKONCO) - Financial and Strategic SWOT Analysis Review

Fresenius Kabi Oncology Limited (FKONCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Fresenius Kabi Oncology Limited (Fresenius Kabi) is a pharmaceutical company. The company develops and manufactures oncology drugs. It provides oral cytotoxics, cytostatics, injectables, intermediates ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication
Guided Therapeutics, Inc. (GTHP) - Financial and Strategic SWOT Analysis Review

Guided Therapeutics, Inc. (GTHP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Guided Therapeutics, Inc. (GTI) is a medical technology company. The company offers products for the non-invasive cervical cancer detection markets. It develops technology to painlessly detect ...

  • Industries : Therapy
Pivotal Therapeutics Inc. (PVO) - Financial and Strategic SWOT Analysis Review

Pivotal Therapeutics Inc. (PVO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Pivotal Therapeutics Inc. (Pivotal Therapeutics) is a pharmaceutical company. The company produces and markets therapeutic products for cardiovascular disease and overall health. Its products include ...

  • Industries : Therapy

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.